United Therapeutics Corp (UTHR)
376.80
+2.78
(+0.74%)
USD |
NASDAQ |
Nov 04, 16:00
372.69
-4.11
(-1.09%)
After-Hours: 07:38
United Therapeutics Gross Profit Margin (Quarterly): 88.90% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 88.90% |
| June 30, 2024 | 89.12% |
| March 31, 2024 | 89.24% |
| December 31, 2023 | 88.45% |
| September 30, 2023 | 88.50% |
| June 30, 2023 | 89.25% |
| March 31, 2023 | 89.68% |
| December 31, 2022 | 88.04% |
| September 30, 2022 | 92.79% |
| June 30, 2022 | 93.64% |
| March 31, 2022 | 94.39% |
| December 31, 2021 | 91.67% |
| September 30, 2021 | 93.77% |
| June 30, 2021 | 91.67% |
| March 31, 2021 | 93.93% |
| December 31, 2020 | 90.96% |
| September 30, 2020 | 93.69% |
| June 30, 2020 | 92.85% |
| March 31, 2020 | 93.43% |
| December 31, 2019 | 90.74% |
| September 30, 2019 | 91.78% |
| June 30, 2019 | 92.85% |
| March 31, 2019 | 91.97% |
| December 31, 2018 | 91.64% |
| September 30, 2018 | 87.42% |
| Date | Value |
|---|---|
| June 30, 2018 | 86.12% |
| March 31, 2018 | 86.33% |
| December 31, 2017 | 88.59% |
| September 30, 2017 | 95.62% |
| June 30, 2017 | 95.75% |
| March 31, 2017 | 96.14% |
| December 31, 2016 | 93.06% |
| September 30, 2016 | 94.22% |
| June 30, 2016 | 95.15% |
| March 31, 2016 | 99.81% |
| December 31, 2015 | 93.75% |
| September 30, 2015 | 98.21% |
| June 30, 2015 | 95.39% |
| March 31, 2015 | 93.65% |
| December 31, 2014 | 95.44% |
| September 30, 2014 | 87.63% |
| June 30, 2014 | 88.01% |
| March 31, 2014 | 89.43% |
| December 31, 2013 | 86.58% |
| September 30, 2013 | 89.84% |
| June 30, 2013 | 88.48% |
| March 31, 2013 | 88.04% |
| December 31, 2012 | 84.55% |
| September 30, 2012 | 88.47% |
| June 30, 2012 | 86.86% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
88.04%
Minimum
Dec 2022
94.39%
Maximum
Mar 2022
91.24%
Average
91.31%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Liquidia Corp | 59.20% |
| Pfizer Inc | 70.27% |
| Tonix Pharmaceuticals Holding Corp | -52.49% |
| Ardelyx Inc | 83.99% |
| Entrada Therapeutics Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 19.26% |
| Return on Assets | 16.08% |
| Return on Invested Capital | 17.45% |
| Profit Margin (Quarterly) | 41.27% |
| Operating Margin (Quarterly) | 54.51% |
| Return on Net Operating Assets | 69.77% |